Current Pharmaceutical Design

Preface [Hot Topic: Treatment of Hypertension, Its Pathophysiology and the Clinical Use of Antihypertensive Drugs (Executive Editor: Gregory Y.H. Lip)]
pp. i-i(1)
Author: Lip, Gregory Y.H.

Drug Development and the Importance of Ethnicity: Lessons from Heart Failure Management and Implications for Hypertension
pp. 3569-3577(9)
Authors: Sosin, Michael D.; Bhatia, Gurbir S.; Lip, Gregory Y.H.; Davis, Russell C.

Sympathetic and Baroreflex Function in Hypertension: Implications for Current and New Drugs
pp. 3579-3589(11)
Author: Grassi, Guido

Endothelial Dysfunction: Methods of Assessment and Application to Hypertension
pp. 3591-3605(15)
Authors: Nadar, Sunil; Blann, Andrew D.; Lip, Gregory Y.H.

Antihypertensive Therapy and Endothelial Function
pp. 3607-3614(8)
Authors: Nadar, Sunil; Blann, Andrew D.; Lip, Gregory Y.H.

Hypertension in Peripheral Arterial Disease
pp. 3615-3620(6)
Authors: Clement, Denis L.; De Buyzere, Marc L.; Duprez, Daniel A.

Pathophysiology and Treatment of Obesity Hypertension
pp. 3621-3637(17)
Authors: Wofford, Marion R.; Hall, John E.

Propofol: Therapeutic Indications and Side-Effects
pp. 3639-3649(11)
Author: Marik, Paul E.

Structurally Modified Analogues of Glucagon-Like Peptide-1 (GLP-1) and Glucose-Dependent Insulinotropic Polypeptide (GIP) As Future Antidiabetic Agents
pp. 3651-3662(12)
Authors: Green, Brian D.; Gault, Victor A.; O'Harte, Finbarr P.M.; Flatt, Peter R.

In Utero Gene Therapy: Prospect and Future
pp. 3663-3672(10)
Authors: Chauhan, D. P.; Srivastava, A. S.; Moustafa, M. E.; Shenouda, S.; Carrier, E.

TNF-Related Apoptosis-Inducing Ligand (TRAIL): A Potential Candidate for Combined Treatment of Hematological Malignancies
pp. 3673-3681(9)
Authors: Secchiero, Paola; Vaccarezza, Mauro; Gonelli, Arianna; Zauli, Giorgio

Point of NO Return for Nitrergic Nerves in Diabetes: A New Insight into Diabetic Complications
pp. 3683-3695(13)
Author: Cellek, S.